Skip to main content

Search

Reset all filters
265 Result(s)
Sort by

More Health Overview

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
Press Material

Press Material

Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view our corporate news. Click here to learn more.
From Idea to Drug

From Idea to Drug

Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
Rare Diseases: Rare but not alone

Rare Diseases: Rare but not alone

We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
The Nagoya Protocol

The Nagoya Protocol

At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do. Read our commitments to the Nagoya Protocol.
Pets

Pets

We continuously innovate and expand our pet health solutions to address unmet needs. Click here to learn more about our work on pet health here.
Accountability

Accountability

Even in ambiguous circumstances, we always demonstrate ownership for our decisions and actions. Click here to learn more about accountability at BI.
COVID-19 and Mental Health

COVID-19 and Mental Health

COVID-19 affects our social lives as well as our mental health. Click here to read suggestions for looking after your mental health during the pandemic.
Intrapreneurship

Intrapreneurship

Together with our customers, we come up with innovative ideas to respond to changing markets. Click here to learn more about intrapreneurship at BI.
Looking behind the scenes of Afrika Kommt!

Looking behind the scenes of Afrika Kommt!

Since inception in 2008, Afrika Kommt! has upskilled over 156 young professionals from Sub-Saharan Africa. Learn more about this programme here.
COVID-19 France Support to Pasteur Institute

COVID-19 France Support to Pasteur Institute

As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
Accessibility Statement

Accessibility Statement

Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible.
Protecting Animals and Humans

Protecting Animals and Humans

At Boehringer Ingelheim we are committed to ensuring the continued availability of our products for patients, customers and animals during the pandemic.
The Supplier Code of Conduct

The Supplier Code of Conduct

Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
Waste

Waste

Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. Learn more.
World Recycling Day: Closing the Loop

World Recycling Day: Closing the Loop

Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
Partnering for innovation and growth

Partnering for innovation and growth

In this interview Dr Frerich de Vries talks about why partnerships are one of the key areas of interest for Boehringer Ingelheim and more. Learn more.
Koropi

Koropi

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Koropi site.
Yamagata

Yamagata

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Yamagata site.